Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Bausch Health Companies Inc |
4/02 | 7,260 USD
-0,27% |
-0,27% |
|
Baxter |
4/02 | 31,420 USD
-0,70% |
-0,70% |
Bayer AG |
4/02 | 21,220 EUR
+1,00% |
+1,00% |
|
Beam Therapeutics Inc |
4/02 | 25,750 USD
+0,63% |
+0,63% |
|
Becton, Dickinson And Co. |
4/02 | 242,420 USD
-2,10% |
-2,10% |
|
BeiGene Ltd |
4/02 | 222,910 USD
-0,21% |
-0,21% |
|
Bellerophon Therapeutics Inc |
18/12 | 0,012 USD
-25,47% |
-25,47% |
|
Bellring Brands Inc |
4/02 | 74,920 USD
-4,26% |
-4,26% |
Benchmark Holdings plc |
3/02 | 28,350 GBX
+0,53% |
+0,53% |
|
Benitec Biopharma Inc |
4/02 | 12,170 USD
+3,14% |
+3,14% |
|
Beximco Pharmaceuticals Limited - GDR - Reg S |
31/01 | 38,500 GBX
0,00% |
0,00% |
|
BeyondSpring Inc |
4/02 | 1,750 USD
+3,48% |
+3,48% |
|
Bicycle Therapeutics Plc |
4/02 | 12,890 USD
+1,82% |
+1,82% |
|
Bio-Path Holdings Inc |
4/02 | 0,733 USD
-3,62% |
-3,62% |
|
Bio-Rad Laboratories Inc. |
4/02 | 346,030 USD
-2,01% |
-2,01% |
|
Bio-Rad Laboratories Inc. |
29/01 | 357,650 USD
+0,17% |
+0,17% |
|
Bio-Techne Corp |
4/02 | 72,550 USD
+0,69% |
+0,69% |
|
BioCardia Inc. |
4/02 | 2,570 USD
+6,64% |
+6,64% |
|
Biocryst Pharmaceuticals Inc. |
4/02 | 8,090 USD
+6,17% |
+6,17% |
|
Biogen |
4/02 | 142,490 USD
+0,11% |
+0,11% |
|
Biohaven Ltd |
4/02 | 39,310 USD
+4,24% |
+4,24% |
|
Biolife Solutions Inc |
4/02 | 26,330 USD
-1,09% |
-1,09% |
|
Bioline Rx Ltd |
4/02 | 3,480 USD
+2,65% |
+2,65% |
|
Biomarin Pharmaceutical Inc. |
4/02 | 62,870 USD
+0,69% |
+0,69% |
|
Biomerica Inc. |
4/02 | 0,441 USD
-6,23% |
-6,23% |
Biomerieux |
4/02 | 116,200 EUR
-0,85% |
-0,85% |
|
BiomX Inc |
4/02 | 0,710 USD
-3,46% |
-3,46% |
|
Bionano Genomics Inc |
4/02 | 5,000 USD
-5,66% |
-5,66% |
|
BioNTech SE |
4/02 | 117,140 USD
-2,24% |
-2,24% |
|
Biophytis |
4/02 | 0,302 EUR
+3,04% |
+3,04% |
|
BioRestorative Therapies Inc |
4/02 | 2,380 USD
+0,85% |
+0,85% |
BioSenic |
4/02 | 0,004 EUR
0,00% |
0,00% |
|
Biosig Technologies Inc |
4/02 | 1,060 USD
+1,92% |
+1,92% |
Biosyent Inc |
4/02 | 11,000 CAD
+0,36% |
+0,36% |
|
Biosynex |
4/02 | 1,102 EUR
-3,16% |
-3,16% |
|
Biotest AG |
4/02 | 41,200 EUR
+0,98% |
+0,98% |
|
Biotest AG |
4/02 | 28,000 EUR
-1,75% |
-1,75% |
|
BioVie Inc |
4/02 | 1,740 USD
+8,75% |
+8,75% |
|
BioXcel Therapeutics Inc |
4/02 | 0,285 USD
-7,38% |
-7,38% |
|
Black Diamond Therapeutics Inc |
4/02 | 2,540 USD
+3,67% |
+3,67% |
|
Bluebird bio Inc |
4/02 | 6,960 USD
-1,00% |
-1,00% |
|
Bluelinea SA |
4/02 | 0,800 EUR
+1,27% |
+1,27% |
|
Blueprint Medicines Corp |
4/02 | 113,400 USD
+1,70% |
+1,70% |
|
Boiron |
4/02 | 25,850 EUR
-2,08% |
-2,08% |
|
Bone Biologics Corp |
4/02 | 1,200 USD
-5,51% |
-5,51% |
|
Boston Scientific Corp. |
4/02 | 103,540 USD
+0,46% |
+0,46% |
|
Boundless Bio Inc. |
4/02 | 2,190 USD
-1,79% |
-1,79% |
|
BRAIN Biotech AG |
4/02 | 2,960 EUR
-0,34% |
-0,34% |
|
Brainstorm Cell Therapeutics, Inc. |
4/02 | 1,840 USD
+0,27% |
+0,27% |
|
Brainsway Ltd |
4/02 | 10,600 USD
+6,53% |
+6,53% |
|
BriaCell Therapeutics Corp |
4/02 | 4,100 USD
-18,65% |
-18,65% |
|
BridgeBio Pharma Inc |
4/02 | 32,980 USD
+6,28% |
+6,28% |
|
Bristol-Myers Squibb Co. |
4/02 | 59,120 USD
-1,38% |
-1,38% |
|
Bruker Corp |
4/02 | 56,390 USD
-0,56% |
-0,56% |